237 related articles for article (PubMed ID: 28476777)
21. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy.
Smedira NG; Lytle BW; Lever HM; Rajeswaran J; Krishnaswamy G; Kaple RK; Dolney DO; Blackstone EH
Ann Thorac Surg; 2008 Jan; 85(1):127-33. PubMed ID: 18154797
[TBL] [Abstract][Full Text] [Related]
22. Extended myectomy for hypertrophic obstructive cardiomyopathy.
Gao C; Ren C; Xiao C; Wu Y; Wang G; Liu G; Wang Y
Heart Surg Forum; 2012 Oct; 15(5):E251-6. PubMed ID: 23092660
[TBL] [Abstract][Full Text] [Related]
23. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
24. Long-term results after myectomy in 64 patients with hypertrophic obstructive cardiomyopathy (HOCM). Morphological and hemodynamic aspects.
Minami K; Woltersdorf H; Kleikamp G; Böthig D; Koertke H; Koerfer R
J Cardiovasc Surg (Torino); 2000 Dec; 41(6):801-6. PubMed ID: 11232962
[TBL] [Abstract][Full Text] [Related]
25. Echocardiographic assessment of left ventricular wall motion in hypertrophic cardiomyopathy.
Gullace G; Knippel M; Ravizza P; Savoia MT
G Ital Cardiol; 1982; 12(8):581-9. PubMed ID: 6892016
[TBL] [Abstract][Full Text] [Related]
26. Left ventricular longitudinal systolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a long-term follow-up study focused on speckle tracking echocardiography.
Sommer A; Poulsen SH; Mogensen J; Thuesen L; Egeblad H
Eur J Echocardiogr; 2010 Dec; 11(10):883-8. PubMed ID: 20667848
[TBL] [Abstract][Full Text] [Related]
27. Cardiac magnetic resonance imaging findings are useful for differentiating between hypertrophic obstructive cardiomyopathy and aortic valve stenosis in elderly patients.
Amano Y; Takayama M; Kumita S
J Comput Assist Tomogr; 2009; 33(3):354-8. PubMed ID: 19478626
[TBL] [Abstract][Full Text] [Related]
28. Surgical aspects of typical subaortic and atypical midventricular hypertrophic obstructive cardiomyopathy (HOCM).
Schulte HD; Bircks W; Körfer R; Kuhn H
Thorac Cardiovasc Surg; 1981 Dec; 29(6):375-80. PubMed ID: 6179220
[TBL] [Abstract][Full Text] [Related]
29. Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
Akita K; Maekawa Y; Kohno T; Tsuruta H; Murata M; Fukuda K
Heart Vessels; 2017 Nov; 32(11):1320-1326. PubMed ID: 28555387
[TBL] [Abstract][Full Text] [Related]
30. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
31. Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy.
Paar V; Haslinger M; Krombholz-Reindl P; Pittner S; Neuner M; Jirak P; Kolbitsch T; Minnich B; Schrödl F; Kaser-Eichberger A; Kopp K; Koller A; Steinwender C; Lichtenauer M; Monticelli FC; Seitelberger R; Hoppe UC; Dinges C; Motloch LJ
Front Pharmacol; 2023; 14():1264216. PubMed ID: 38074139
[No Abstract] [Full Text] [Related]
32. Delayed untwisting: the mechanistic link between dynamic obstruction and exercise tolerance in patients with hypertrophic obstructive cardiomyopathy.
Wang J; Buergler JM; Veerasamy K; Ashton YP; Nagueh SF
J Am Coll Cardiol; 2009 Sep; 54(14):1326-34. PubMed ID: 19778676
[TBL] [Abstract][Full Text] [Related]
33. Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis.
Clemmensen TS; Soerensen J; Hansson NH; Tolbod LP; Harms HJ; Eiskjær H; Mikkelsen F; Wiggers H; Andersen NF; Poulsen SH
J Am Heart Assoc; 2018 Nov; 7(21):e009974. PubMed ID: 30571379
[TBL] [Abstract][Full Text] [Related]
34. Minimally invasive septal myectomy for the treatment of hypertrophic obstructive cardiomyopathy and intrinsic mitral valve disease.
Gilmanov DSh; Bevilacqua S; Solinas M; Ferrarini M; Kallushi E; Santarelli P; Farneti PA; Glauber M
Innovations (Phila); 2015; 10(2):106-13. PubMed ID: 25803770
[TBL] [Abstract][Full Text] [Related]
35. Surgical Treatment for Hypertrophic Obstructive Cardiomyopathy with Concomitant Mitral Valve Abnormalities: A Cohort of 26 Cases.
Song BR; Ren Y; Zhang HJ
Heart Surg Forum; 2018 Nov; 21(6):E443-E447. PubMed ID: 30604666
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
Lösse B; Loogen F; Schulte HD
Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
[TBL] [Abstract][Full Text] [Related]
37. Regional myocardial function by tissue Doppler in hypertrophic cardiomyopathy: the impact of obstruction.
Cardim N; Oliveira AG; Castela S; Longo S; Ferreira T; Pereira A; Reis RP; Correia JM
Rev Port Cardiol; 2002 Dec; 21(12):1413-35. PubMed ID: 12621916
[TBL] [Abstract][Full Text] [Related]
38. Myocardial blood flow and oxygen consumption in patients with Friedreich's ataxia prior to the onset of cardiomyopathy.
Gregory SA; MacRae CA; Aziz K; Sims KB; Schmahmann JD; Kardan A; Morss AM; Ellinor PT; Tawakol A; Fischman AJ; Gewirtz H
Coron Artery Dis; 2007 Feb; 18(1):15-22. PubMed ID: 17172925
[TBL] [Abstract][Full Text] [Related]
39. Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study.
Tuunanen H; Kuusisto J; Toikka J; Jääskeläinen P; Marjamäki P; Peuhkurinen K; Viljanen T; Sipola P; Stolen KQ; Hannukainen J; Nuutila P; Laakso M; Knuuti J
J Nucl Cardiol; 2007; 14(3):354-65. PubMed ID: 17556170
[TBL] [Abstract][Full Text] [Related]
40. [Surgical treatment for hypertrophic obstructive cardiomyopathy].
Castedo E; Cabo RA; Núñez I; Monguió E; Montero CG; Burgos R; Serrano-Fiz S; Téllez G; González M; Cavero MA; Ugarte J
Rev Esp Cardiol; 2004 Aug; 57(8):751-6. PubMed ID: 15282064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
